David Toung
Stock Analyst at Argus Research
(3.31)
# 1,033
Out of 5,005 analysts
127
Total ratings
63.27%
Success rate
9.79%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Buy | $80 → $90 | $68.22 | +31.93% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $97.70 | +17.71% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $283.72 | -0.61% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $350.50 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $35.81 | +45.21% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $543.32 | -13.49% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $360.20 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $14.80 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $233.91 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $154.46 | -19.07% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $177.33 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $297.89 | +14.14% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $738.06 | -9.22% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $100.78 | +48.84% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $839.87 | +0.02% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $76.56 | +43.68% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $276.94 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $27.37 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $370.50 | -16.33% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $429.54 | -27.83% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $452.35 | -29.26% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $134.59 | +0.30% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $112.69 | -33.45% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $45.45 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $89.19 | +23.33% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.01 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $62.95 | +94.60% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $85.31 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $132.39 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $188.64 | -17.83% | 4 | Mar 27, 2020 |
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $68.22
Upside: +31.93%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $97.70
Upside: +17.71%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $283.72
Upside: -0.61%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $350.50
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $35.81
Upside: +45.21%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $543.32
Upside: -13.49%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $360.20
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $14.80
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $233.91
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $154.46
Upside: -19.07%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $177.33
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $297.89
Upside: +14.14%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $738.06
Upside: -9.22%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $100.78
Upside: +48.84%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $839.87
Upside: +0.02%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $76.56
Upside: +43.68%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $276.94
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $27.37
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $370.50
Upside: -16.33%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $429.54
Upside: -27.83%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $452.35
Upside: -29.26%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $134.59
Upside: +0.30%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $112.69
Upside: -33.45%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $45.45
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $89.19
Upside: +23.33%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.01
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $62.95
Upside: +94.60%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $85.31
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $132.39
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $188.64
Upside: -17.83%